Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb Max Pain By Strike
BMY trades at $47.2, pinned near the near-term max pain of $48 expiring Sep 5, 2025 (5 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($45-$52.5), signaling increased put positioning or downside protection. Key magnetic zone at 47 where 5 expirations converge.
Bristol-Myers Squibb Max Pain By Expiry
Max pain for BMY shows a downward trend from 52.5 to 45, indicating bearish sentiment or hedging activity. The 16% spread signals divergent expectations across timeframes. Levels distributed around 47.2. Strong magnetic level at 47 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 5, 2025 | 48 | 0.80 (1.68%) |
| Sep 12, 2025 | 47 | -0.20 (-0.43%) |
| Sep 19, 2025 | 47 | -0.20 (-0.43%) |
| Sep 26, 2025 | 47 | -0.20 (-0.43%) |
| Oct 3, 2025 | 48 | 0.80 (1.68%) |
| Oct 10, 2025 | 50 | 2.80 (5.92%) |
| Oct 17, 2025 | 45 | -2.20 (-4.67%) |
| Nov 21, 2025 | 47 | -0.20 (-0.43%) |
| Dec 19, 2025 | 49 | 1.80 (3.80%) |
| Jan 16, 2026 | 49 | 1.80 (3.80%) |
| Mar 20, 2026 | 45 | -2.20 (-4.67%) |
| Jun 18, 2026 | 50 | 2.80 (5.92%) |
| Sep 18, 2026 | 45 | -2.20 (-4.67%) |
| Dec 18, 2026 | 47 | -0.20 (-0.43%) |
| Jan 15, 2027 | 52.5 | 5.30 (11.22%) |
| Jun 17, 2027 | 52.5 | 5.30 (11.22%) |
| Dec 17, 2027 | 52.5 | 5.30 (11.22%) |